Market Overview: Cancer Profiling Market FY2024-2030
This reports provides an essential and dependable overview of the Cancer Profiling Market, serving as a guide for stakeholders navigating the industry’s future trajectory. It covers critical aspects, guiding through challenges and opportunities, shedding light on the market landscape, key insights, driving forces, major competitors, regulatory framework, potential growth, ongoing trends, supply chain dynamics, evolving policies, segments and prominent players.
Cancer Profiling Market Report Coverage Details:
- Base Year: 2023
- Historical Data: 2019-22
- Forecast Period: 2024-2030
- CAGR: 11.5% (2024-2030)
The Global Cancer Profiling Market size is estimated to grow at a CAGR of around 11.5% during the forecast period, i.e., 2024-30.
In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Boost strategic growth with in-depth market analysis – Get a free sample preview today!- https://www.marknteladvisors.com/query/request-sample/cancer-profiling-market.html
Cancer Profiling Market Opportunity:
Advancements in Bioinformatics Techniques to Improve Testing Outcome and Support Market Growth – In recent years, companies like Amazon, M2GEN, FOXO Technologies, etc., have been focussing on introducing their upgraded bioinformatics software and services, especially for the oncology market. These services are designed to provide fast, highly reliable, and secure software to process and analyze vast amounts of genomic, and proteomic data.
The introduction of advanced bioinformatics tools and services within the Global Cancer Profiling Market is enabling the expansion of cancer research and diagnostics services across various domains. Notably, companies have recently intensified their efforts in areas such as targeted therapies and drug discovery.
Therefore, with the rollout of advanced bioinformatics services, there is a significant potential for enhancing the efficacy of tumor profiling in cancer research and diagnostics in the foreseeable future. This is mainly because advanced bioinformatics services are expected to streamline operations and reduce turnaround times for market players, presenting them with growth opportunities in the coming years.
Cancer Profiling Market Segmentation Analysis – FY2024-2030
Discover a comprehensive evaluation of every segment and its subdivisions, allowing our clients to gain a deep understanding of the Cancer Profiling Market (2024-2030). We prioritize uncovering the pivotal factors that presently drive and will shape the industry’s growth moving forward. Our goal is to empower our esteemed clients by optimizing their end-user positioning and revenue generation through a thorough analysis of market size, share and all the latest market scope across diverse segmentation categories.
The Cancer Profiling Market segmentation is enlisted below:
By Type of Cancer
- Breast Cancer – Market Size & Forecast 2019-2030, USD Million
- Colorectal Cancer – Market Size & Forecast 2019-2030, USD Million
- Gynecological Cancer – Market Size & Forecast 2019-2030, USD Million
- Leukemia – Market Size & Forecast 2019-2030, USD Million
- Prostate Cancer – Market Size & Forecast 2019-2030, USD Million
- Lung Cancer – Market Size & Forecast 2019-2030, USD Million
- Others (Pancreatic Cancer, Skin Cancer, etc.) – Market Size & Forecast 2019-2030, USD Million
By Technology
- Next-Generation Sequencing – Market Size & Forecast 2019-2030, USD Million
- Polymerase Chain Reaction – Market Size & Forecast 2019-2030, USD Million
- Mass Spectrometry – Market Size & Forecast 2019-2030, USD Million
- In-Situ Hybridization – Market Size & Forecast 2019-2030, USD Million
- Microarrays Analysis – Market Size & Forecast 2019-2030, USD Million
- Others (Single-Cell Sequencing, etc.) – Market Size & Forecast 2019-2030, USD Million
By Biomarker Type
- Genomic Biomarkers- Market Size & Forecast 2019-2030, USD Million
- Proteomics Biomarkers- Market Size & Forecast 2019-2030, USD Million
- Others (Epigenetic Biomarkers, Metabolomics Biomarkers, etc.)- Market Size & Forecast 2019-2030, USD Million
By Cell Type
- Germline – Market Size & Forecast 2019-2030, USD Million
- Somatic – Market Size & Forecast 2019-2030, USD Million
By Application
- Oncology Research – Market Size & Forecast 2019-2030, USD Million
- Precision Medicine – Market Size & Forecast 2019-2030, USD Million
- Clinical Diagnostics – Market Size & Forecast 2019-2030, USD Million
- Others (Prognosis, Monitoring and Recurrence Detection, etc.) – Market Size & Forecast 2019-2030, USD Million
Buy specific sections of the report directly from the Table of Contents https://www.marknteladvisors.com/research-library/cancer-profiling-market.html
By End-User
- Hospitals and Clinics – Market Size & Forecast 2019-2030, USD Million
- Research Institutions and Laboratories – Market Size & Forecast 2019-2030, USD Million
- Diagnostic Service Providers – Market Size & Forecast 2019-2030, USD Million
- Pharmaceutical and Biotechnology Companies – Market Size & Forecast 2019-2030, USD Million
By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia Pacific
Cancer Profiling Market Competitive Landscape
NeoGenomics Laboratories, Eurofins Genomics GmbH, F. Hoffmann-La Roche Ltd (Foundation Medicine) , OncoDNA SA, 10x Genomics, Inc., Caris Life Sciences., Geneseeq Technology Inc., Genetron , Holdings Limited, Laboratory Corporation of America Holdings (LabCorp), Dante Labs Inc., Celemics, Inc., Strand Life Sciences, Myriad Genetics, Inc., QIAGEN GmbH, Tempus Labs, Others.
Cancer Profiling Industry News:
- 2023: Caris Life Sciences, a leading molecular science and healthcare innovation company announced that it is conducting four studies covering 14 tumor types, which would allow leveraging blood for precise cancer detection, monitoring, and therapy selection. These discoveries are significant observations, especially in the context of endometrial and prostate cancer.
Request Customization – https://www.marknteladvisors.com/query/request-customization/cancer-profiling-market.html
Key Report Highlights
- Market Dimensions & Projections
- Pricing Evaluation,
- Recent Strategic Moves by Companies,
- Primary Stakeholders,
- Analysis of Import and Export Trends,
- Competitive Landscape Assessment,
- Emerging Opportunities,
- Market Trends and Indicators
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
About Us:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Our Expertise is here to assist you : https://www.marknteladvisors.com/query/talk-to-our-consultant/cancer-profiling-market.html
Call Us – US Office: +1 628 895 8081, India Office: +91 120 4278433
Email – sales@marknteladvisors.com
Address Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Follow us – Facebook| LinkedIn| Twitter| Pinterest
